Home > 暂无记录 暂无记录 行业新闻

行业新闻


  • avelumab  MA1010

    Avelumab, a human IgG1 anti–PD-L1 monoclonal antibody, has demonstrated clinical activity with a range of human cancers and has been approved for the treatment of Merkel cell and bladder carcinoma.

    More

  • Basiliximab MA1011

    Basiliximab is a monoclonal antibody that binds to the α-chain of the interleukin (IL)-2 receptor and used as induction therapy in kidney transplantation.

    More

  • belimumab MA1012

    Belimumab (LymphoStat B), a fully humanised mAb against B lymphocyte stimulator (B-LyS), is the first drug to be approved specifically for the treatment of SLE.

    More

  • Abciximab MA1005

    More

  • Brompheniramine hydrogen maleate EY2861

    Brompheniramine hydrogen maleate is a histamine H1 receptors antagonist.

    More
    • Current page9, Total Pages305, Total Record1522 First Prev 7891011 Next Last Goto
More